| (Values in U.S. Thousands) | Dec, 2012 | Dec, 2011 | Dec, 2010 | Dec, 2009 | Dec, 2008 |
| Sales | 1,960 | 8,080 | 5,580 | 6,690 | 6,470 |
| Sales Growth | -75.74% | +44.80% | -16.59% | +3.40% | -22.52% |
| Net Income | -1,050 | -880 | -1,470 | -1,080 | -3,040 |
| Net Income Growth | -19.32% | +40.14% | -36.11% | +64.47% | +24.75% |
Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Bioject Medical Technologies Inc. develops, manufactures and markets jet injection systems for needle-free drug delivery. The company sells its products directly to healthcare providers. The company also licenses its technology to leading pharmaceutical and biotechnology companies for whose products the company's technology provides increased medical efficacy or enhanced market acceptance.
Fiscal Year End Date: 12/31